Another area of interest lies in elucidating the pleiotropic properties of agents that ameliorate hypertriglyceridemia, particularly peroxisome proliferator-activated receptor alpha (PPARa) agonists such as fibrates. This evidence concerns the gene PPARA and hypertriglyceridemia.